Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JAMA Editorials Call For Tough FDA Sanctions, Device Coding, To Ensure Post-Market Safety

Executive Summary

Two Harvard Medical School professors argue US FDA should put pressure on device manufacturers to complete their post-market studies by withdrawing market authority for devices when sponsors do not meet post-approval commitments. Meanwhile, in the same issue of the Journal of the American Medical Association, a Michigan University researcher suggests tracking products with device-specific CPT codes.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT105252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel